Mr. Pauly brings over 25 years of extensive commercial launch experience in the biopharmaceutical industry, spanning multiple therapeutic areas and a wide range of commercial functions, including sales, account management, marketing, and market access. Most recently, he served as Chief Commercial Officer at Alzheon, where he focused on advancing treatments in the Alzheimer's space. Prior to that, Mr. Pauly held leadership roles at Biogen, AstraZeneca, Genentech, and Johnson & Johnson, where he played a pivotal role in the successful launches of innovative therapies addressing critical unmet medical needs.